©istock.com/Andrea Obzerova
Interdisziplinäre KompetenzMolekulare Diagnostik
Know how bei der Analyse von Erbmaterial.
Zum Wohle von Patienten.

ErkrankungGestörte mitochondriale DNA-Instandhaltung, Differentialdiagnose

Zusammenfassung

Kurzinformation

Umfassendes differentialdiagnostisches panel für Gestörte mitochondriale DNA-Instandhaltung / mtDNA maintenance disorders mit 25 Leitlinien-kuratierten sowie insgesamt 27 kuratierten Genen

ID
MP3354
Anzahl Gene
26 Akkreditierte Untersuchung
Untersuchte Sequenzlänge
37,2 kb (Core-/Basis-Gene)
42,8 kb (Erweitertes Panel)
Analyse-Dauer
auf Anfrage
Material
  • EDTA-Blut (3-5 ml)
Diagnostische Hinweise

MP3354_DH

 

Genpanel

Ausgewählte Gene

NameExon-Länge (bp)OMIM-GErbgang
ABAT1503AR
AFG3L22394AD und/oder AR
AGK1269AR
DGUOK834AR
DNA23183AD und/oder AR
FBXL41866AR
GFER618AR
MFN22274AD und/oder AR und/oder Dig und/oder Sus
MGME11035AR
MPV17531AR
OPA12883AD und/oder AR und/oder Mult
POLG3720AD und/oder AR
POLG21458AD und/oder AR
RNASEH1869AR
RRM2B1272AD und/oder AR
SLC25A21897AR
SLC25A4897AD und/oder AR
SPG72388AD und/oder AR
SUCLA21392AR
SUCLG11041AR
TFAM645AR
TK2705AR
TWNK2055AD und/oder AR
TYMP1449AR
DNM22613AD und/oder AR und/oder SMu
TOP3A3006AR

Infos zur Erkrankung

Klinischer Kommentar

illness_ClinicalComment_MP3354

 

Synonyme
  • Allelic: Optic atrophy 5 (DNM1L)
  • Behr syndrome (OPA1)
  • Cataract 38, AR (AGK)
  • Centronuclear myopathy 1 (DNM2)
  • Charcot-Marie-Tooth disease, axonal type 2M (DNM2)
  • Charcot-Marie-Tooth disease, axonal, type 2A2A (MFN2)
  • Charcot-Marie-Tooth disease, axonal, type 2A2B (MFN2)
  • Charcot-Marie-Tooth disease, axonal, type 2EE (MPV17)
  • Charcot-Marie-Tooth disease, dominant intermediate B (DNM2)
  • Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1 (DNM1L)
  • GABA-transaminase deficiency (ABAT)
  • Glaucoma, normal tension, susceptibility to (OPA1)
  • Hereditary motor + sensory neuropathy VIA (MFN2)
  • Lethal congenital contracture syndrome 5 (DNM2)
  • Microcephaly, growth restriction + increased sister chromatid exchange 2 (TOP3A)
  • Mitochondrial DNA depletion syndrome 1 [MNGIE type] (TYMP)
  • Mitochondrial DNA depletion syndrome 11 (MGME1)
  • Mitochondrial DNA depletion syndrome 12A [cardiomyopathic type] (SLC25A4)
  • Mitochondrial DNA depletion syndrome 12B [cardiomyopathic type] (SLC25A4)
  • Mitochondrial DNA depletion syndrome 13 [encephalomyopathic type] (FBXL4)
  • Mitochondrial DNA depletion syndrome 14 [encephalocardiomyopathic type] (OPA1)
  • Mitochondrial DNA depletion syndrome 15 [hepatocerebral type] (TFAM)
  • Mitochondrial DNA depletion syndrome 16 [hepatic type] (POLG2)
  • Mitochondrial DNA depletion syndrome 18 (SLC25A21)
  • Mitochondrial DNA depletion syndrome 2 [myopathic type] (TK2)
  • Mitochondrial DNA depletion syndrome 3 [hepatocerebral type] (DGUOK)
  • Mitochondrial DNA depletion syndrome 4A [Alpers type] (POLG)
  • Mitochondrial DNA depletion syndrome 4B [MNGIE type] (POLG)
  • Mitochondrial DNA depletion syndrome 5 [encephalomyopathic +/- methylmalonic aciduria] (SUCLA)
  • Mitochondrial DNA depletion syndrome 6 [hepatocerebral type] (MPV17)
  • Mitochondrial DNA depletion syndrome 7 [hepatocerebral type] (TWNK)
  • Mitochondrial DNA depletion syndrome 8A [encephalomyopathic with renal tubulopathy] (RRM2B)
  • Mitochondrial DNA depletion syndrome 8B [MNGIE type] (RRM2B)
  • Mitochondrial DNA depletion syndrome 9 [encephalomyopathic type + methylmalonic aciduria] (SUCLG1)
  • Mitochondrial recessive ataxia syndrome [includes SANDO + SCAE] (POLG)
  • Myopathy, mitochondrial progressive, congenital cataract + developmental delay (GFER)
  • Optic atrophy 1 (OPA1)
  • Optic atrophy 12 (AFG3L2)
  • Optic atrophy plus syndrome (OPA1)
  • Perrault syndrome 5 (TWNK)
  • Portal hypertension, noncirrhotic (DGUOK)
  • Progressive external ophthalmoplegia with mitochondrial DNA deletions, AD 2 (SLC25A4)
  • Progressive external ophthalmoplegia with mitochondrial DNA deletions, AD 3 (TWNK)
  • Progressive external ophthalmoplegia with mitochondrial DNA deletions, AD 4 (POLG2)
  • Progressive external ophthalmoplegia with mitochondrial DNA deletions, AD 5 (RRM2B)
  • Progressive external ophthalmoplegia with mitochondrial DNA deletions, AD 6 (DNA2)
  • Progressive external ophthalmoplegia with mitochondrial DNA deletions, AR 2 (RNASEH1)
  • Progressive external ophthalmoplegia with mitochondrial DNA deletions, AR 3 (TK2)
  • Progressive external ophthalmoplegia with mitochondrial DNA deletions, AR 4 (DGUOK)
  • Progressive external ophthalmoplegia with mitochondrial DNA deletions, AR 5 (TOP3A)
  • Progressive external ophthalmoplegia, AD 1 (POLG)
  • Progressive external ophthalmoplegia, AR 1 (POLG)
  • Seckel syndrome 8 (DNA2)
  • Sengers syndrome (AGK)
  • Spastic ataxia 5, AR (AFG3L2)
  • Spastic paraplegia 7, AR (SPG7)
  • Spinocerebellar ataxia 28 (AFG3L2)
Erbgänge, Vererbungsmuster etc.
  • AD und/oder AR
  • AD und/oder AR und/oder Dig und/oder Sus
  • AD und/oder AR und/oder Mult
  • AD und/oder AR und/oder SMu
  • AR
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code
G31.81

Bioinformatik und klinische Interpretation

Kein Text hinterlegt